Moneycontrol
HomeNewsBusinessStartupTo reduce dependence on Zomato and Swiggy, restaurants seek own delivery platform

To reduce dependence on Zomato and Swiggy, restaurants seek own delivery platform

In a virtual town hall, top industry officials stress on the need to prepare for a post- Covid19 world.

May 06, 2020 / 16:14 IST
Story continues below Advertisement

The restaurant industry that has been clashing with food delivery platforms over prices and commissions is planning its own digital offerings and delivery services to reduce dependence on aggregators such as Swiggy and Zomato.

Hit hard by the coronavirus outbreak and the lockdown, restaurants are also looking at a common loyalty programme that can help the business grow in the future, which will be very different from the pre-coronavirus world.

Story continues below Advertisement

“Aggregators have become virtual landlords, they came in trying to solve a genuine problem but eventually they are just decimating the small businesses with their business policies,” Thomas Fenn, a National Restaurant Association of India (NRAI) member, said addressing a virtual town hall on May 6.

The industry should work together to create an alternate technology solution to expand business in the post-Covid19 world, Fenn, who owns the popular Mahabelly restaurant in New Delhi, said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show